钱钧强, 孙 蓓, 综述, 何景华, 审校. 抗肿瘤药物多药耐药性的研究进展[J]. 中国肿瘤临床, 2011, 38(11): 684-687. DOI: 10.3969/j.issn.1000-8179.2011.11.023
引用本文: 钱钧强, 孙 蓓, 综述, 何景华, 审校. 抗肿瘤药物多药耐药性的研究进展[J]. 中国肿瘤临床, 2011, 38(11): 684-687. DOI: 10.3969/j.issn.1000-8179.2011.11.023
Junqiang QIAN, Bei SUN, Jinghua HE, . Research on Multidrug Resistance against Antineoplastic Agents[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 38(11): 684-687. DOI: 10.3969/j.issn.1000-8179.2011.11.023
Citation: Junqiang QIAN, Bei SUN, Jinghua HE, . Research on Multidrug Resistance against Antineoplastic Agents[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 38(11): 684-687. DOI: 10.3969/j.issn.1000-8179.2011.11.023

抗肿瘤药物多药耐药性的研究进展

Research on Multidrug Resistance against Antineoplastic Agents

  • 摘要: 在恶性肿瘤的治疗手段中,化疗一直占据着不可替代的地位。联合化疗虽然对一些恶性肿瘤有明显的治疗效果,但对大多数恶性肿瘤效果并不理想,主要原因在于肿瘤细胞对化疗药物产生了多药耐药性。研究证明,MDR的发生是肿瘤细胞从细胞膜、细胞质和细胞核内多种途径,包括细胞信号传导、能量转换、解毒系统、DNA合成等多个环节综合作用的结果,其形成机制非常复杂。MDR的产生机制尚不明确,目前已提出几种可能的机制。根据肿瘤细胞的多药耐药机制,人们先后应用钙离子通道阻滞剂、免疫抑制剂、蛋白激酶抑制剂以及中药等药物作为逆转剂,取得了不同的作用效果。

     

    Abstract: Chemotherapy is irreplaceable in the treatment of malignant tumors.  Although combined chemotherapy has evident therapeutic efficacy on some malignant tumors, the curative effect is not quite satisfactory in most malignant tumors because of the multidrug-resistance (MDR) of the tumor cells to chemotherapy. Studies have shown that the occurrence of MDR involves a very complicated mechanism. It is caused by synthetic action that includes a variety of pathways, such as the cell membrane, cytoplasm, and the nucleus, which combines the effects of cell signal transduction, energy conversion, detoxification, and DNA synthesis among others. The mechanism of MDR remains unclear until now and, presently, several potential mechanisms have been proposed. Based on the multidrug-resistant mechanism of the tumor cells, some reversal agents, such as the calcium channel blockers, immunosuppressants, and protein kinase inhibitor, as well as Chinese crude drugs have been used and different effects have been achieved.

     

/

返回文章
返回